GK
GKB Ophthalmics Ltd (GKB)
₹61.99
Mkt cap
₹34 Cr
P/E ratio
9.26
P/B
0.59
Div yield
0.00%
ROE
3.28%
ROCE
10.90%
EPS (TTM)
₹6.69
Book value
₹105
52W range
14–92
Sector
Healthcare
Price history
Previous close
Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic. [1]
NSE GKBBSE 533212
Health check
Mixed
ValuationCheap
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−32.25% from high₹62
₹14+335.02% from low₹92
Current
₹61.99
Prev close
₹61.60
Day
+0.63%
Price performance
1D
+0.63%
1W
−5.17%
1M
−5.79%
3M
+31.75%
6M
+54.98%
1Y
+234.18%
YTD
−4.63%
Financials
Revenue, profit & margin
P/E ratio
9.3×
GKB is 72% below the sector median of 33.1×
GKB9.3×
Sector median33.1×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22.26 | 20.40 | 24.04 | 21.56 | 26.02 | 26.14 | 25.80 | 31.02 | 32.31 | 30.17 | 56.79 | 29.79 | 33.04 | |
| Expenses | 20.91 | 20.69 | 24.66 | 21.56 | 24.98 | 26.20 | 26.74 | 33.88 | 31.51 | 27.15 | 55.13 | 26.71 | 30.41 | |
| Operating Profit | 1.35 | -0.29 | -0.62 | 0.00 | 1.04 | -0.06 | -0.94 | -2.86 | 0.80 | 3.02 | 1.66 | 3.08 | 2.63 | |
| OPM % | 6.06% | -1.42% | -2.58% | 0.00% | 4.00% | -0.23% | -3.64% | -9.22% | 2.48% | 10.01% | 2.92% | 10.34% | 7.96% | |
| Other Income | 0.35 | 0.31 | 0.35 | 0.60 | 0.28 | 0.28 | 0.48 | 0.35 | 0.21 | 0.37 | 0.57 | -0.68 | 0.73 | |
| Interest | 0.43 | 0.46 | 0.44 | 0.57 | 0.55 | 0.55 | 0.63 | 0.63 | 0.77 | 0.66 | 0.73 | 0.52 | 0.51 | |
| Depreciation | 0.72 | 0.73 | 0.73 | 0.72 | 0.76 | 0.77 | 0.77 | 0.80 | 0.80 | 0.82 | 0.82 | 0.80 | 0.80 | |
| Profit before tax | 0.55 | -1.17 | -1.44 | -0.69 | 0.01 | -1.10 | -1.86 | -3.94 | -0.56 | 1.91 | 0.68 | 1.08 | 2.05 | |
| Tax % | 0.00% | 0.00% | 0.00% | 30.43% | 600.00% | 5.45% | 2.69% | 4.82% | 14.29% | 3.66% | -4.41% | -3.70% | 9.76% | |
| Net Profit | 0.54 | -1.19 | -1.44 | -0.89 | 0.11 | -1.15 | -1.91 | -4.13 | -0.64 | 1.84 | 0.70 | 1.12 | 1.85 | |
| EPS in Rs | 1.03 | -2.32 | -2.48 | -1.81 | -0.50 | -2.42 | -4.03 | -7.04 | -2.02 | 3.17 | 0.87 | 0.38 | 2.00 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202651.15%Promoter
Promoters51.15%0.02
FIIs1.79%
Public47.07%0.02
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Poly Medicure | ₹1,726.00 | 54.67 | 17,495 | 0.20% | 85 | −7.57% | 525 | +30.30% | 12.50% |
| Molbio Diagnosti | ₹1,288.30 | 59.47 | 14,846 | 0.00% | 53 | +347.79% | 408 | +309.57% | 18.48% |
| Fischer Medical | ₹33.15 | 94.61 | 2,316 | 0.15% | 4 | −22.02% | 82 | +249.49% | 11.38% |
| Tarsons Products | ₹306.10 | 137.55 | 1,629 | 0.00% | −1 | −180.90% | 110 | +20.67% | 4.59% |
| Q-Line Biotech | ₹696.95 | 28.79 | 1,626 | 0.00% | 34 | +147.29% | 198 | −8.59% | 22.46% |
| Laxmi Dental | ₹197.95 | 31.32 | 1,089 | 0.00% | 10 | +22.77% | 75 | +13.87% | 15.05% |
| Vasa Denticity | ₹420.40 | 60.26 | 729 | 0.00% | 4 | +45.99% | 82 | +36.90% | 9.21% |
| GKB Ophthalmics | ₹67.44 | 9.26 | 34 | 0.00% | 2 | +199.02% | 33 | +2.26% | 10.90% |
| Median: 17 Co. | ₹342.40 | 33.09 | 603 | 0.00% | 4 | +19.77% | 75 | +21.48% | 15.14% |
Filings
Annual reports15
Credit ratings6
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 26 Aug - 44th AGM voting results announced; all 7 resolutions passed with requisite majority on August 25, 2026.Shareholder Meeting / Postal Ballot-Outcome of AGM 25 Aug - GKB Ophthalmics held its 44th AGM on August 25, 2026; voting results to follow within 48 hours.Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Aug - Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, …Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026. 12 AugBoard Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd., Held On August 12, 2026 12 Aug - Board approved Q1 FY27 results; challenged ₹8.82 crore recovery demand and wrote off closed subsidiary investment.